576
|
Sokollik T, Shiraishi S, Osterhoff J, Evans E, Gonsalves AJ, Nakamura K, van Tilborg J, Lin C, Toth C, Leemans WP, Gold SH, Nusinovich GS. Tape-Drive Based Plasma Mirror. ACTA ACUST UNITED AC 2010. [DOI: 10.1063/1.3520320] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
577
|
Lin A, Lin C, Chow K, Looi J, Looi K, Lee M, White H, Ellis C. Acute Coronary Syndrome Patients Treated with Coronary Artery Bypass Surgery Have Poor Cholesterol Control and Significant Adverse Events at Review 3 Years Later. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
578
|
Strom A, Hartman J, Lam E, Lin C, Gustafsson J, Gustafsson J. Function of HES6 an Inhibitor of HES1, in the Breast Cancer Cell Lines T47D and MCF-7 Is to Up-Regulate E2F-1 and Increased Proliferation. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-09-2153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Hormone resistance remains as a major obstacle in breast cancer treatment. The majority of breast tumors are dependent on estrogens to grow, therefore anti-estrogens such as Tamoxifen is an effective treatment option. We have found that a transcription factor Hes6, earlier described in the nervous tissue, is up-regulated in hormone-independent breast cancer cells compared to normal estrogen sensitive breast cancer cells. By using a lenti-virus system, we have over-expressed Hes6 in T47D cells which are estrogen sensitive. This resulted in increased proliferation. We also found that estrogen treatment of MCF-7 breast cancer cells induced expression of endogenous Hes6 in the G1-phase. We could not find any binding of estrogen receptor α to the HES6 gene but instead found a binding site up-steam of the promoter in the ASCL1 gene. ASCL1 is a known inducer of HES6 and we are showing that ASCL1 is up-regulated by 17β-estradiol in MCF-7 cells. To find the mechanism behind the tumorogenic effects of Hes6, we analysed important factors of the cell-cycle. We found that the G1-phase factor E2F-1 was up-regulated in response to increased Hes6 expression. Since HES6 have been shown to be an inhibitor of HES1, this is in agreement with a previous study where we found that HES1 inhibited proliferation by binding to the promoter of and down-regulating E2F-1 expression. E2F-1 is an important limiting factor in late G1-phase of the cell cycle and can drive cell proliferation.We believe that the HES1-HES6 interplay is important in antiestrogen-resistant breast cancer. Studies are now ongoing to investigate if Hes6 is up-regulated in estrogen-independent human breast cancer samples.
Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 2153.
Collapse
|
579
|
Lin C. P1.227 Cerebral infratentorial large B-cell lymphoma presenting as parkinsonism. Parkinsonism Relat Disord 2009. [DOI: 10.1016/s1353-8020(09)70349-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
580
|
Lin CJ, Wang SL, Huang PM, Tzou YM, Liu JC, Chen CC, Chen JH, Lin C. Chromate reduction by zero-valent Al metal as catalyzed by polyoxometalate. WATER RESEARCH 2009; 43:5015-5022. [PMID: 19729183 DOI: 10.1016/j.watres.2009.08.015] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/12/2009] [Revised: 08/05/2009] [Accepted: 08/14/2009] [Indexed: 05/28/2023]
Abstract
In spite of a high reduction potential of zero-valent Al (ZVAl), its ability to reduce Cr(VI), a widespread pollutant, to less toxic Cr(III) remains to be uncovered. In the present study, Cr(VI) reduction by ZVAl was conducted to evaluate the potential application of Al as a reductant for Cr(VI). Polyoxometalate (POM, HNa(2)PW(12)O(40)), a catalyst, was used to accelerate Cr(VI) reduction by Al. The reaction of 0.192mM Cr(VI) on ZVAl was investigated in the presence of N(2) or O(2) at pH 1. A slight decrease in Cr(VI) concentration was observed on as-received (uncleaned) ZVAl due to the presence of oxide layer with a low surface area (ca. 3.4x10(-3)m(2)/g) of ZVAl. On addition of 0.1mM POM, Cr(VI) reduction on uncleaned ZVAl increased significantly. This is attributed to the unique properties of POM, which has a Brphinsted acidity higher than usual inorganic acids such as H(2)SO(4) and HCl. Thus, POM could remove rapidly the oxidize layer on ZVAl, followed by acting as a shuttle for electron transfer from ZVAl to Cr(VI). Under a N(2) atmosphere, one- or two-electron reduction of POM by ZVAl was responsible for Cr(VI) reduction in the early stage of the reaction. However, during reaction with ZVAl over 120min, three-electron reduction of POM predominated over Cr(VI) reduction. On interaction of O(2) with reduced POM, the formation of H(2)O(2) was responsible for subsequent Cr(VI) reduction. The results suggest that POM is an efficient catalyst for Cr(VI) reduction by Al due to the extremely rapid consumption of reduced POM or H(2)O(2) by Cr(VI).
Collapse
|
581
|
Lin C, Loberiza F. Association of Patient Factors with use of Preoperative Radiation Therapy for Stage II and III Rectal Cancer. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
582
|
Wang YH, Lin C, Lai YC, Chang-Chien GP. Characterization of PCDD/Fs, PAHs, and heavy metals in a secondary aluminum smelter. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH. PART A, TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING 2009; 44:1335-1342. [PMID: 20183490 DOI: 10.1080/10934520903213087] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
This study characterizes polychlorinated dibenzo-p-dioxins/dibenzofurans (PCDD/Fs), polycyclic aromatic hydrocarbons (PAHs), and heavy metal concentrations in stack flue gas, workplace air, fly ash, bottom ash, and ambient air of a secondary aluminum smelter. The total PAH concentration in workplace air was dominated by 2- and 3-ring PAHs, accounting for 86.2% of the gas phase in the total PAHs. The PCDD/F concentrations in workplace air are 1-7 fold higher than that in ambient air. The mass distribution ratio for total PCDD/Fs was soil > ash > workplace air > ambient air > flue gas. Aluminum and Zn had the highest concentrations. A positive correlation existed between PCDD/Fs and PAHs concentrations (r(2) = 0.920). The operation of secondary aluminum smelter affects the pollutant concentrations and surrounding air quality. Experimental results suggest that besides the terminal control technologies for stack flue gases, engineering control technologies in the workplace need further improvement.
Collapse
|
583
|
Zhao C, Xiao W, Han F, Lu L, Huang S, Wu S, Chen C, Chen J, Lin C, Deng X. Long-term Results and Prognostic Factors of Primary Nasopharyngeal Carcinoma Patients Treated with Intensity Modulated-Radiotherapy. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
584
|
Yang R, Lin G, Ning H, Guo H, Dai Y, Sun Z, Lin C, Lue T. UP-3.101: Notable Promotion of Neurite Out Growth in Major Pelvic Ganglion through Cytokine Secretion by Adipose Stem Cells. Urology 2009. [DOI: 10.1016/j.urology.2009.07.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
585
|
Darras B, Lin C, Fogerson P, Butler H, Caracciolo J, Rutkove S. M.P.4.05 Electrical impedance myography for non-invasive quantification of spinal muscular atrophy. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
586
|
Chang J, Chen L, Lin C, Fan K, Chen E. 8566 Primary tumour site as a predictor of treatment outcome for definitive radiotherapy of advanced stage oral cavity cancers. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71657-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
587
|
Tsai S, Lin C. Effects of cryoprotectant on the embryos of banded coral shrimp (Stenopus hispidus); preliminary studies to establish freezing protocols. CRYO LETTERS 2009; 30:373-381. [PMID: 19946659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The addition of cryoprotectants is a necessary step in cryopreservation procedures because they can minimize cellular injury during cryopreservation. Toxicity of cryoprotectant depends on the type, concentration, temperature and exposure period. The aim of this study was to investigate the toxicity of cryoprotectant to embryos of banded coral shrimp (Stenopus hispidus) in order to inform the development of a cryopreservation protocol. Three stages of embryonic development (eye-formation, heart beat and pre-hatch stage) embryos were selected and exposed to different concentration of cryoprotectants (0.25M-5M) for an equilibration period of 10, 20 or 30 min at room temperature. Hatching percentage indicated that the toxicity of tested cryoprotectants increased in the order of methanol, ethylene glycol (EG), dimethyl sulphoxide (DMSO), glycerol and dimethylacetamide (DMA). The No Observed Effect Concentrations (NOECs) for eye-formation stage embryos were 1M, 0.25M, 0.25M, 0.25M and 0.25M respectively after 10 min incubation whilst the NOECs for heart beat and pre-hatch stage embryos were 1M, 0.5M, 0.5M, 0.5M and 0.25M respectively. Pre-hatch stage embryos appeared to be more tolerant to cryoprotectant toxicity than eye-formation and heart beat stage embryos.
Collapse
|
588
|
Kuan K, Wang B, Chang J, Shiau R, Lin C, Juang Y. 4226 The impacts and adjustment of the spouse of head and neck cancer patient in Taiwan. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70843-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
589
|
Lin C, Spikings E, Zhang T, Rawson D. Effect of chilling and cryopreservation on expression of Pax genes in zebrafish (Danio rerio) embryos and blastomeres. Cryobiology 2009; 59:42-7. [DOI: 10.1016/j.cryobiol.2009.04.007] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2009] [Revised: 02/16/2009] [Accepted: 04/09/2009] [Indexed: 10/20/2022]
|
590
|
Liu Y, Lin C, Ma Y, Lu W, Wu Y, Huang S, Zhu L, Li J, Chen A. Toxic effects of two acid sulfate soils from the Dabaoshan Mine on Corymbia citriodora var.variegata and Daphnia carinata. JOURNAL OF HAZARDOUS MATERIALS 2009; 166:1162-1168. [PMID: 19157696 DOI: 10.1016/j.jhazmat.2008.12.017] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/23/2008] [Revised: 12/02/2008] [Accepted: 12/02/2008] [Indexed: 05/27/2023]
Abstract
Acidic, metal-stressed conditions encountered in the acid sulfate soils significantly inhibited the growth of Corymbia citriodora var.variegata, possibly due to the reduced rate of photosynthesis and plant root activity. However, the plant's self-protection mechanism to counteract stress-induced cellular damage by reactive oxygen species still functioned well even at a soil pH as low as 2.81. This may explain the high tolerance of this plant species to the extremely acidic environments. The observed phytotoxicity symptoms were not accompanied by elevated concentrations of heavy metals in the plant tissues, suggesting that heavy metal levels in plant tissue alone are not valid indications of phytotoxicity to the tested plant species. Leachates from the acid sulfate soils had strong toxicity to Daphnia carinata. Median lethal dilution factor (LDF50) was much higher for the leachate from the highly acidic acid sulfate soils (ASS) than that from the mildly acidic ASS. Although the concentration of various metals markedly decreased with increasing number of leaching cycle, leachate toxicity to Daphnia carinata did not decrease accordingly. This suggests that levels of heavy metals and Al in the leachate are not good indicators of the mine water biotoxicity.
Collapse
|
591
|
Ellisman M, Hutton T, Kirkland A, Lin A, Lin C, Molina T, Peltier S, Singh R, Tang K, Trefethen A, Wallom D, Xiong X. The OptIPuter microscopy demonstrator: enabling science through a transatlantic lightpath. PHILOSOPHICAL TRANSACTIONS. SERIES A, MATHEMATICAL, PHYSICAL, AND ENGINEERING SCIENCES 2009; 367:2645-2653. [PMID: 19487201 PMCID: PMC3268213 DOI: 10.1098/rsta.2009.0058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The OptIPuter microscopy demonstrator project has been designed to enable concurrent and remote usage of world-class electron microscopes located in Oxford and San Diego. The project has constructed a network consisting of microscopes and computational and data resources that are all connected by a dedicated network infrastructure using the UK Lightpath and US Starlight systems. Key science drivers include examples from both materials and biological science. The resulting system is now a permanent link between the Oxford and San Diego microscopy centres. This will form the basis of further projects between the sites and expansion of the types of systems that can be remotely controlled, including optical, as well as electron, microscopy. Other improvements will include the updating of the Microsoft cluster software to the high performance computing (HPC) server 2008, which includes the HPC basic profile implementation that will enable the development of interoperable clients.
Collapse
|
592
|
Lu C, Ning N, Peng D, Ding G, Li K, Yang Y, Lin C. The role of large-scale neural interactions for developmental stuttering. Neuroscience 2009; 161:1008-26. [PMID: 19364522 DOI: 10.1016/j.neuroscience.2009.04.020] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2008] [Revised: 03/30/2009] [Accepted: 04/06/2009] [Indexed: 12/21/2022]
|
593
|
Lee H, Chong N, Tien H, Lin C, Yen H, Shueng P, Wu L, Hsieh C, Chen C. SU-FF-T-342: Evaluation of Superficial Dose for Helical Tomotherapy with GAFCHROMIC® EBT Film. Med Phys 2009. [DOI: 10.1118/1.3181823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
594
|
Zhang D, Singhvi M, Lin C, Lin K, Lee S, Lee P, Zachary Z, Hussain A, Steinberg M, DeMarco J. SU-FF-J-15: A Retrospective Study of the Variation in Organ Dose as a Function of Table Shifts Using Megavoltage Cone-Beam CT. Med Phys 2009. [DOI: 10.1118/1.3181307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
595
|
Lin C, Moore D, DeMichele A, Ollila D, Montgomery L, Liu M, Krontiras H, Gomez R, Esserman L. Detection of locally advanced breast cancer in the I-SPY TRIAL (CALGB 150007/150012, ACRIN 6657) in the interval between routine screening. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.1503] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
1503 Background: It is assumed that most locally advanced breast cancers (LABC) could be detected at an earlier stage with routine screening. However, LABCs may present between screens as interval cancers (IC). ICs present at an earlier age, with higher grade, larger size, and are associated with lower survival, compared to screen-detected cancers (SDC), and comprise 17% of cancers from population-based screening programs. We evaluated the screening history in patients with LABCs from the I SPY TRIAL, to determine the frequency of screening and ICs. Methods: Of 221 pts enrolled in the I-SPY TRIAL, a multisite neoadjuvant study for women with LABCs > 3cm in size, screening history and presentation were retrospectively collected for 154. Two groups, screened (S), defined as a mammogram within 2 years, or non screened (NS), previous mammogram more than 2 years prior, were evaluated (Table). The frequency of ICs at 1 and 2 years was determined in S pts. Frequency of mammographically occult (MO) tumors was determined for all. Results: Of the total, 99 (64%) and 55 (36%) were NS and S, respectively. Mean tumor size for all pts was 6.7cm. Only 11 (20%) of S pts were SDCs and 44 (80%) were ICs, with 24 (63%) diagnosed within 1 year and 14 (37%) between 1 and 2 yrs of their last normal mammogram. 24 (24%) NS patients were younger than the recommended screening age of 40; in the remaining 75 pts, 9 (12%) were MO. Only 20% of IC tumors were MO. ICs were of higher grade (44% vs 11% grade III), and tumor size (7.0cm vs 4.4cm) than their SDC counterparts. 80% of cancers detected in I SPY were NKI70 gene test poor prognosis. Relationship to breast density and subtype is currently being assessed. Conclusions: Women presenting with LABCs have a high likelihood (80%) of an IC. This suggests that the growth rate of LABCs precludes early detection by conventional screening. Understanding the biology of ICs will be important to develop better strategies for prevention and early detection. [Table: see text] No significant financial relationships to disclose.
Collapse
|
596
|
van 't Veer LJ, Esserman LJ, Linn S, Rutgers E, Knauer M, Retel V, Davis SE, Lin C. Evaluation of the effect of screening on the detection of good and poor prognosis breast cancers. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.1525] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
1525 Background: Since the advent of screening, breast cancer incidence has significantly increased in the United States as well as other countries. SEER data from the US shows that the increase is largely in localized disease without a concomitant or significant decrease in regionalized disease. In addition, the increase has occurred essentially in women over 50. We asked whether molecular characterization of tumors would shed light on the types of tumors detected in screening and in locally advanced breast cancers (LABC). Methods: We identified two groups of patients from European studies before and after the introduction of population based screened (in 1995) where the 70-gene prognosis test (MammaPrint) results were available. The first source is the European Validation Study (EVS) (Buyse et al, J Natl Cancer Inst. 2006). The second was a prospective implementation trial of MammaPrint in the Netherlands (RASTER study) (Bueno de Mesquita et al, Lancet Oncol. 2007). The source of LABC patients comes from the multicenter I-SPY TRIAL (CALGB 150007/150012) who underwent routine screening (prior mammogram within 2 years of diagnosis). Results: In women age 50–60, the fraction of cancers that were MammaPrint good prognosis were 40% and 60% prior to and after the introduction of screening, respectively. For women 50–60 who were actually undergoing screening, the fraction of tumors that were MammaPrint good prognosis was 67%. For patients aged 30–40 with stage I and II lymph node-negative disease, who did not undergo screening in either period, the fraction of MammaPrint good prognosis tumors did not change (29% and 31%, for EVS and Raster, respectively). For patients with LABC, from the I-SPY TRIAL, the fraction of tumors that are MammaPrint good prognosis is 7% and 29% for women aged 30–40 and 50–60, respectively. Of the LABC patients undergoing screening, 80% presented clinically during the interval between routine mammograms. Conclusions: Current screening programs are increasing the burden of low-risk cancers. Screening programs should consider including molecular profiles at the time of diagnosis to reduce overtreatment. The majority of LABCs have high-risk molecular profiles and do not present as screen detected cancers. New strategies are needed for early detection of LABC. [Table: see text]
Collapse
|
597
|
Lin C, Chen Y. Protective role of silibinin on matrix metalloproteinase-2 and activator protein-1 on LoVo cells. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e15136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e15136 Background: Silibinin, a flavonoid and the major active component of milk thistle, has been as a safe diet supplement for several decades. It has been proved with anti-hepatotoxic properties and pleiotropic anticancer capabilities. Current study aimed to investigate the role of silibinin as potential therapeutic target of colon cancer through antiangiogenesis and its related molecular mechanisms with matrix metalloproteinase- 2 (MMP-2) and activator protein-1 (AP-1). Colon cancer cell line, LoVo cells, treated with a major prognostic factor, interleukin-6 (IL-6), was studied. Methods and Results: By western blot analysis, silibinin suppressed MMP- 2 protein expression in time- and concentration-dependent manners. Furthermore, the inhibitors of JNK/AP-1 binding activity abolished the expression of MMP-2 in IL-6-stimulated LoVo cells, but not PI3K pathways. We also demonstrated that silibinin inhibited IL-6- stimulated LoVo cell migration and further tumor angiogenesis, which similar to the effects from addition with AP-1 inhibitor. By EMSA, the binding activity of AP-1 in LoVo cells was also decreased with silibinin treatment. In addition, the imaging of confocal microscopy revealed that AP-1 presentation was attenuated on IL-6-stimulated LoVo cells plus silibinin treatment. Conclusions: Taken together, these data indicated that silibinin inhibits angiogenesis through the suppression of MMP-2 expression and AP-1 binding activity in colon cancer cells. It suggests a novel anti-metastatic application of silibinin in colon cancer chemoprevention. No significant financial relationships to disclose.
Collapse
|
598
|
Lin C, Hsu C, Cheng JC, Lee J, Tsai Y, Luo J, Hsu F, Wang H, Lee Y, Cheng A. Induction chemotherapy followed by concurrent chemoradiotherapy with/without esophagectomy for locally advanced esophageal squamous cell carcinoma. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e15526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e15526 Background: To assess the feasibility of preoperative induction chemotherapy in addition to concurrent chemoradiotherapy (CCRT) followed by esophagectomy if possible for locally advanced esophageal squamous cell carcinoma (ESCC) with a special emphasis on M1a or nodal M1b disease. Methods: Patients who had histologic proof of T3N1M0, M1a, or nodal M1b ESCC first received up to 3 courses of induction chemotherapy (paclitaxel 70 mg/m2 or docetaxel 40 mg/m2 IV 1-hr D 1, 8; cisplatin 35 mg/m2 IV 2-hr D 1, 8; 5-fluorouracil 2000 and leucovorin 300 mg/m2 IV 24-hr D 1, 8; repeated every 28 days). This was followed by CCRT (paclitaxel 35 mg/m2 1-hr D 1, 4 /wk, cisplatin 15 mg/m2 1-hr D 2, 5/wk, and radiotherapy 2 Gy D 1–5 /wk) (Lin CC et al. Ann Oncol 18:93–8,2007). When the accumulated radiation dose reached 40 Gy, the feasibility of esophagectomy was evaluated in all patients. In patients for whom esophagectomy was not feasible, CCRT was continued to a dose of 60 Gy. Results: Fifty-six patients (M:F = 51:5, median age 58, range 41–78) with locally advanced (T3N1M0:M1a:M1b[nodal] = 30:7:19) ESCC (upper:mid:lower = 15:25:16) were enrolled from June 22, 2006 to December 17, 2008. By December 31, 2008, 10 patients are still under protocol treatment. Eighteen (T3N1:M1a:M1b[nodal] = 14:3:1) (40%) and 20 of 46 patients underwent surgery and continued CCRT up to 60 Gy, respectively. Nine (T3N1:M1a:M1b[nodal] = 7:2:0) (20%) and 5 patients had pathologic complete response and microscopic residual disease, respectively. With a median follow-up of 8.4 months (range 0.5–30.8), 17 (T3N1:M1a:M1b[nodal] = 9:2:6) patients had relapse. Four and 13 patients had local recurrence and distant metastasis, respectively. The median progression-free survival was 20.3 months. The median overall survival had not reached yet with 1- and 2-year overall survival being 76 and 57%, respectively. There was no difference in progression- free or overall survival among patients with T3N1M0, M1a, or nodal M1b disease. Conclusions: Three-step strategy of preoperative taxane-based induction chemotherapy then CCRT followed by esosphagectomy if possible appears quite active in locally advanced ESCC patients with 46% having M1a or nodal M1b disease. No significant financial relationships to disclose.
Collapse
|
599
|
Lin C, Huang C, Lu Y, Laiu J, Huang S, Kuo W, Kuo W, Chang K, Cheng A. Evaluation of estrogen receptor expression as a prognostic factor for very young women (below 35 years) with breast cancer in Taiwan. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e22163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e22163 Background: In the past two decades, the incidence of very young (<35 years) breast cancer in Taiwanese has been rapidly increasing to quite close to that of Caucasian Americans. However, the clinicopathological features of this group of patients appear to be different from their Western counterpart. Here, we sought to determine the prognostic value of ER expression for this newly emerging population in Taiwan. Methods: We retrospectively collected information on all consecutive very young patients (age <35 years) with stage I-III breast cancer treated at National Taiwan University Hospital between 1997 and 2005. ER expression was evaluated by immunohistochemistry on formalin-fixed paraffin-embedded tissue sections. Tumor with more than 10% positive nuclei was considered ER positive. Results: A total of 178 patients with a median age of 32 (range: 21–35) years were included. The median follow-up time was 62.5 (95% confidence interval, 42.0–64.2) months. Univariate analysis showed that ER expression was significantly associated with favorable OS (HR=0.48, P=0.03), but not with DFS (hazard ratio [HR]=0.79, P=0.42). Multivariate analysis showed that stage and ER were independent prognostic factors. Conclusions: In contrast to the findings in Caucasians, ER expression was an independent prognostic factor for favorable overall survival in Taiwanese patients with very young breast cancer. No significant financial relationships to disclose.
Collapse
|
600
|
Kuo S, Chen L, Wu M, Hsu C, Lin C, Hsu P, Yeh K, Tzeng Y, Cheng A. Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide—the molecular mechanism and the clinical application. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e19512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e19512 Background: We have recently demonstrated that nuclear expression of BCL10 or NF-κB helps predict H. pylori-independent status; and inflammatory cytokines such as TNF-α may be related to BCL10 nuclear translocation (Blood 2005;106:1037–41;J Biol Chem 2006;281:167–75). Recent studies have been shown that the chimeric protein of t(11;18)(q21;q21) can lead to constitutive NF-κB activity and thereby mediate cell survival and anti-apoptotic signals. The present study was conducted to investigate the molecular mechanism and the clinical efficacy of thalidomide, an TNF-α or NF-κB inhibitor, in H. pylori-independent MALT lymphoma. Methods: Between October 2003 and June 2007, our study enrolled 11 H. pylori-independent MALT lymphoma patients ( 7 men and 4 women; age range, 43 to 79 years; 7 patients who had failed chemotherapy or rituximab) with nuclear expression of BCL10 or NF-κB in pretreatment lymphoma tissues treated at National Taiwan University Hospital with thalidomide 100mg to 200 mg oral given daily. The presence of t(11;18)(q21;q21) was identified by a multiplex reverse transcriptase polymerase chain reaction of the API2-MALT1 chimeric transcript. Results: Three (27.3%) of 11 patients achieved a complete response (CR), and 3 (27.3) of 11 patients achieved a partial response (PR), resulting in an overall response rate of 54.5% (95% CI, 19.5%-89.6%). The median time from thalidomide therapy to CR was 3.0 months (range, 2.7–4.9 months). At a median follow-up of 41.6 months (range, 17.7–63.8 months), the 3-year event-free survival and overall survival after thalidomide treatment was 80.8%, and 88.9%, respectively. The API2-MALT1 fusion transcript for t(11;18)(q21;q21) was detected in 1 (16.7%) of 6 patients with CR or PR, and 4 (80.0%) of 5 patients with stable or progressive disease (P = 0.08). Conclusions: Our results indicate that thalidomide can be an adjuvant treatment for H. pylori-independent MALT lymphoma patients. Additional investigation of the molecular mechanisms and biologic significance of the API2-MALT1 fusion transcript responsible for thalidomide resistance in this group of tumors is needed. No significant financial relationships to disclose.
Collapse
|